News

TipRanks on MSN6d
Novo Nordisk’s IcoSema Study: A New Horizon in Diabetes Treatment
Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Novo Nordisk has completed a 40-week clinical study titled ‘A ...
Cheaper generic Ozempic is coming to Canada after Novo Nordisk fails to pay patent fee
In what Science magazine has dubbed “Novo Nordisk’s Canadian Mistake,” Ozempic is soon to come off patent in Canada, opening ...